243 related articles for article (PubMed ID: 22183772)
1. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.
Gueron G; De Siervi A; Vazquez E
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):213-21. PubMed ID: 22183772
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory mediators enhance prostate cancer development and progression.
Thapa D; Ghosh R
Biochem Pharmacol; 2015 Mar; 94(2):53-62. PubMed ID: 25593038
[TBL] [Abstract][Full Text] [Related]
4. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
[TBL] [Abstract][Full Text] [Related]
7. Genetic and microenvironmental implications in prostate cancer progression and metastasis.
Alberti C
Eur Rev Med Pharmacol Sci; 2008; 12(3):167-75. PubMed ID: 18700688
[TBL] [Abstract][Full Text] [Related]
8. Recent role of inflammation in prostate diseases: chemoprevention development opportunity.
Hamid AR; Umbas R; Mochtar CA
Acta Med Indones; 2011 Jan; 43(1):59-65. PubMed ID: 21339547
[TBL] [Abstract][Full Text] [Related]
9. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and metabolism in prostate cancer.
Chiarugi P; Paoli P; Cirri P
Semin Oncol; 2014 Apr; 41(2):267-80. PubMed ID: 24787298
[TBL] [Abstract][Full Text] [Related]
12. Prostate inflammation and its potential impact on prostate cancer: a current review.
Haverkamp J; Charbonneau B; Ratliff TL
J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
[TBL] [Abstract][Full Text] [Related]
13. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
Servais C; Erez N
J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer and inflammation: interaction of chemokines and hnRNPs.
Tauler J; Mulshine JL
Curr Opin Pharmacol; 2009 Aug; 9(4):384-8. PubMed ID: 19570713
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
Narayanan NK; Nargi D; Horton L; Reddy BS; Bosland MC; Narayanan BA
Prostate; 2009 Feb; 69(2):133-41. PubMed ID: 18819100
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
17. Inflammation: gearing the journey to cancer.
Kundu JK; Surh YJ
Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
[TBL] [Abstract][Full Text] [Related]
18. ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype.
Smith AM; Findlay VJ; Bandurraga SG; Kistner-Griffin E; Spruill LS; Liu A; Golshayan AR; Turner DP
Carcinogenesis; 2012 Mar; 33(3):572-80. PubMed ID: 22232738
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
Wang L; Alcon A; Yuan H; Ho J; Li QJ; Martins-Green M
Integr Biol (Camb); 2011 Jul; 3(7):742-54. PubMed ID: 21594291
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of chemokines in prostate cancer.
Vindrieux D; Escobar P; Lazennec G
Endocr Relat Cancer; 2009 Sep; 16(3):663-73. PubMed ID: 19556286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
